no remarkable differences were found between two groups of patients with thyroid cancer , the first one being treated with thyroid eliminating dose in attempt to activate the metastases of functionally differentiated tumour , while the second one was treated with similar doses ( i. e. 100 to 200 mci ) to suppressor destroy a functionally active tumour or its metastases .
C0007115
thyroid cancer
C0040132
thyroid